In Japan, a patient received an iPS stem cell transplant in October to treat Parkinson's disease, marking a first in the context of a treatment deemed promising by Sumitomo Pharma after clinical trials. #MaladieDeParkinson #CellulesSouches #SoinInnovant (translated)